CHADDS FORD, Pa., Feb. 9 /PRNewswire-FirstCall/ -- Endo Pharmaceuticals Holdings Inc. , a market leader in pain management, will announce its financial results for the fourth quarter and full-year ended December 31, 2005 before the market opens on Wednesday, February 15, 2006, and will hold a conference call at 11:00 a.m. ET that day to discuss those results. Peter A. Lankau, president and chief executive officer, and Jeffrey R. Black, executive vice president and chief financial officer, will host the call.
Investors and other interested parties may access the conference call as follows:
Telephone Numbers
(800) 305-2862 (domestic), (706) 634-1979 (international)
Please dial in 10 minutes prior to the scheduled start time and reference conference code 5284111.
Replay
A replay of the call will be available from February 15 at 12:30 p.m. ET by dialing (800) 642-1687 (domestic) or (706) 645-9291 (international), passcode 5284111, and will run until 12:00 a.m. ET on February 22, 2006.
Webcast
A simultaneous webcast of the call for interested investors and others may be accessed by visiting http://www.endo.com. In addition, a replay of the webcast will be available until 12:00 a.m. ET on February 22, 2006. The replay can be accessed by clicking on “Events” in the Investor Relations section of the website.
About Endo
Endo Pharmaceuticals Holdings Inc. is a fully integrated specialty pharmaceutical company with market leadership in pain management products. Through its Endo Pharmaceuticals Inc. subsidiary, the company researches, develops, produces and markets a broad product offering of branded and generic pharmaceuticals, meeting the needs of healthcare professionals and consumers alike. More information, including this and past press releases of Endo Pharmaceuticals Holdings Inc., is available online at http://www.endo.com.
Endo Pharmaceuticals Holdings Inc.
CONTACT: Bill Newbould of Endo Pharmaceuticals, +1-610-558-9800
Web site: http://www.endo.com/
